AU573574B2 - Immunogenic deteminants of foot and mouth disease virus - Google Patents

Immunogenic deteminants of foot and mouth disease virus

Info

Publication number
AU573574B2
AU573574B2 AU25428/84A AU2542884A AU573574B2 AU 573574 B2 AU573574 B2 AU 573574B2 AU 25428/84 A AU25428/84 A AU 25428/84A AU 2542884 A AU2542884 A AU 2542884A AU 573574 B2 AU573574 B2 AU 573574B2
Authority
AU
Australia
Prior art keywords
deteminants
immunogenic
foot
disease virus
mouth disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU25428/84A
Other versions
AU2542884A (en
Inventor
Hendrik Mario Geysen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiron Mimotopes Pty Ltd
Stichting Centraal Diergeneeskundig Instituut
Original Assignee
Commonwealth Serum Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Serum Laboratories filed Critical Commonwealth Serum Laboratories
Priority to PCT/AU1984/000038 priority Critical patent/WO1984003506A1/en
Priority to AU25428/84A priority patent/AU573574B2/en
Publication of AU2542884A publication Critical patent/AU2542884A/en
Application granted granted Critical
Publication of AU573574B2 publication Critical patent/AU573574B2/en
Assigned to CHIRON MIMOTOPES PTY LTD reassignment CHIRON MIMOTOPES PTY LTD Request to Amend Deed and Register Assignors: COSELCO MIMOTOPES PTY LTD
Assigned to CHIRON MIMOTOPES PTY LTD, STICHTING CENTRAAL DIERGENEESKUNDIG INSTITUUT reassignment CHIRON MIMOTOPES PTY LTD Alteration of Name(s) in Register under S187 Assignors: CHIRON MIMOTOPES PTY LTD
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/222—Foot and mouth disease related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
AU25428/84A 1983-03-08 1984-03-08 Immunogenic deteminants of foot and mouth disease virus Ceased AU573574B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/AU1984/000038 WO1984003506A1 (en) 1983-03-08 1984-03-08 Antigenically active amino acid sequences
AU25428/84A AU573574B2 (en) 1983-03-08 1984-03-08 Immunogenic deteminants of foot and mouth disease virus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPF8347 1983-03-08
AU25428/84A AU573574B2 (en) 1983-03-08 1984-03-08 Immunogenic deteminants of foot and mouth disease virus

Publications (2)

Publication Number Publication Date
AU2542884A AU2542884A (en) 1984-09-20
AU573574B2 true AU573574B2 (en) 1988-06-16

Family

ID=3714230

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25428/84A Ceased AU573574B2 (en) 1983-03-08 1984-03-08 Immunogenic deteminants of foot and mouth disease virus

Country Status (1)

Country Link
AU (1) AU573574B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619826B2 (en) * 1988-04-22 1992-02-06 Aventis Pharma Deutschland Gmbh A synthetic vaccine against foot and mouth disease and a process for the preparation thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592311B2 (en) * 1984-07-24 1990-01-11 Coselco Mimotopes Pty Ltd Method for determining mimotopes
CA1255586A (en) * 1984-07-24 1989-06-13 Hendrik M. Geysen Method of determining mimotopes
WO1986006487A1 (en) * 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Method for determining mimotopes
CA1327096C (en) * 1985-12-26 1994-02-15 Marta I. Sabara Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
EP0390612A1 (en) 1989-03-31 1990-10-03 Synbiotics Corporation Drug production using non-cross reactive antibodies

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040922A1 (en) * 1980-05-12 1981-12-02 Biogen N.V. DNA sequences, recombinant DNA molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens
AU1255383A (en) * 1982-03-26 1983-09-29 Biogen N.V. Foot and mouth disease viral antigenic peptides
WO1983003547A1 (en) * 1982-04-14 1983-10-27 Bittle, James, L. Synthetic picornavirus antigen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040922A1 (en) * 1980-05-12 1981-12-02 Biogen N.V. DNA sequences, recombinant DNA molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens
AU1255383A (en) * 1982-03-26 1983-09-29 Biogen N.V. Foot and mouth disease viral antigenic peptides
WO1983003547A1 (en) * 1982-04-14 1983-10-27 Bittle, James, L. Synthetic picornavirus antigen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619826B2 (en) * 1988-04-22 1992-02-06 Aventis Pharma Deutschland Gmbh A synthetic vaccine against foot and mouth disease and a process for the preparation thereof

Also Published As

Publication number Publication date
AU2542884A (en) 1984-09-20

Similar Documents

Publication Publication Date Title
AU1255383A (en) Foot and mouth disease viral antigenic peptides
JPS6425800A (en) T-cell epitope of hepatities b virus nucleocapside protein
AU7211787A (en) Intraocular dosage compositions and method of use
GB2103622B (en) Production of foot and mouth disease vaccine from microbially expressed antigens
AU5821286A (en) Synthetic vaccines for foot and mouth disease
PT85760A (en) Vaccine and method of preparation
AU8015587A (en) 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
AU7258887A (en) Encapsulated halogen bleaches and methods of preparation and use
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
AU7749687A (en) Oral sustained release preparation of sodium monofluorophosphate
AR243081A1 (en) Synthetic vaccins against foot and mouth disease and their preparation process
IL71470A0 (en) Novel galenic forms of sulpirid suitable for oral administration and their preparation
PT85405A (en) Method of inhibiting virus replication and disease
IL81920A0 (en) Vaccines and their preparation
ZA824174B (en) Production of foot and mouth disease vaccine from microbially expressed antigens thereof
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
AU585494B2 (en) Live attenuated human rotavirus vaccine and preparation thereof
GB2216122B (en) Preparation of bromofluoromethane
ZA828574B (en) Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it
AU7237087A (en) Vaccine and implant
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent
ZW26082A1 (en) Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it
AU629103C (en) Vaccine and method of preparation
IL66042A0 (en) Production of foot and mouth disease vaccine from microbially expressed antigens thereof